OpenLegislation

Regulation 80 Amendment of regulation 71 (withdrawal of medicinal product from the market)I1

United Kingdom

(1)

Regulation 71 M1 is amended as follows.

(2)

In paragraph (1)—

(a)

for sub-paragraph (a) substitute—

“(a)

under regulation 68 the licensing authority revokes or suspends a UK marketing authorisation or parallel import licence; or”; and

F1(b)

for sub-paragraph (b) substitute—

“(b)

under—

(i)

regulation 69 the licensing authority suspends the use, sale, supply or offer for sale or supply within Great Britain of a product to which a UKMA(GB) relates; or

(ii)

regulation 69 or Article 20(4) of Regulation (EC) No 726/2004 the licensing authority suspends the use, sale, supply or offer for sale or supply within Northern Ireland of a product to which a UKMA(NI) or UKMA(UK) relates.”.

Annotations

Textual amendments

F1

Reg. 80(2)(b) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 58

Marginal citations

M1

Regulation 71 was amended by S.I. 2014/1878.

Commencement

I1

Reg. 80 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1